Mederi Therapeutics Inc
GREENWICH, Connecticut, December 5, 2011 -
- Novel Study Confirms Effect of Radiofrequency Energy Delivery at Gastroesophageal Junction (GEJ) and Excludes Fibrosis as Underlying Cause
- Stretta Significantly Improves GERD Symptoms and Decreases GEJ Compliance
Mederi Therapeutics Inc.
GREENWICH, Connecticut, November 21, 2011 -
- Comprehensive Review Offers the Ins and Outs of Bowel Control Disorder (BCD)
In a new paper published today inTouch Gastroenterology, the researcher addresses the immediate need for a reasoned, stepwise algorithm for treating bowel control disorder (BCD), also known asfecal incontinence (FI).
Mederi Therapeutics Announces Receipt of FDA 510(k) Clearance for the MDRF1 Radiofrequency Generator
GREENWICH, Connecticut, January 31, 2011 - Mederi Therapeutics Inc.
GREENWICH, Connecticut, November 8, 2010 - Mederi Therapeutics Inc announced today that it has received a CE Mark
authorizing the European distribution and use of Mederi's second generation
of the Stretta and Secca Systems.
